Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss increases with age and is triggered by hormones like androgens.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Alopecia X causes hair loss in young plush-coated dogs and can be treated with various therapies, but hair may regrow and then fall out again.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Lowering testosterone speeds up wound healing in male mice.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Deslorelin can help regrow hair in most intact male dogs with alopecia.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride helps reduce heart issues and improves heart function.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Estrogen therapy helped regrow hair in a bald man.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.